NCT03565770 (DIAB-HELP) is a NA clinical trial of individual coaching in Diabetes type1, sponsored by University Hospital, Lille.

Who is sponsoring NCT03565770?

NCT03565770 is sponsored by University Hospital, Lille.

What drugs are being tested in NCT03565770?

Interventions in NCT03565770: individual coaching, Standard care.

What condition does NCT03565770 study?

NCT03565770 studies Diabetes type1.

Is NCT03565770 still recruiting?

NCT03565770 is currently completed. Last updated 23 December 2025.

Last reviewed 2025-12-23 · How we verify

NCT03565770: DIAB-HELP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Individual Follow-up by Coaching Program for Type 1 Diabetes Children

Completed NA Last updated 23 December 2025

What this trial tests

NA trial testing individual coaching in Diabetes type1 in 106 participants. Completed in 25 June 2021.

Timeline

29 September 2018

Primary endpoint
25 June 2021

25 June 2021

Quick facts

Lead sponsor	University Hospital, Lille
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	106
Start date	29 September 2018
Primary completion	25 June 2021
Estimated completion	25 June 2021
Sites	1 location across France

Drugs / interventions tested

individual coaching
Standard care — full drug profile →

Conditions studied

Diabetes type1 — all drugs for Diabetes type1 →

Sponsor

University Hospital, Lille

Who can join

Under 18, any sex, with Diabetes type1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this project is to assess the introduction of an individual follow-up distance coaching (phone and messages on a secure line platform) in order to optimize the health care of type 1 diabetes children with therapy adjustment difficulties. It is a personalized, multi-disciplinary, medical et paramedical. It will consist of an individual coaching for the children and families with therapy adjustment difficulties. The hypothesis is that the proposed coaching would allow to improve the patient glycemic control not only during this coaching, but also, to bring long lasting improvement following the coaching.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of individual coaching

Trials testing the same drug.

NCT06811077 — Evaluation of Individual Health Coaching Sessions Provided by a Patient Expert As Part of Therapeutic Education for Pati · recruiting

Other recruiting trials for Diabetes type1

Currently open trials in the same condition.

NCT06405373 — Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART · NA · recruiting
NCT06411210 — Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment · Phase 2 · recruiting
NCT06460558 — T1D Closed-loop and Physical Activity · recruiting
NCT06190756 — Impact of Gravity on Cardiac Hemodynamics · NA · recruiting

Other University Hospital, Lille trials

Trials by the same sponsor.

NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03565770 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
Last refreshed: 23 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03565770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing